|
|
This is only a preview of the paper
Click here to register and get the full text.
Existing members click here to login
|
|
|
“They (biopsychiatrists) search for signs of hyperactivity in the dopamine system of schizophrenics without acknowledging that if they find it, it could be the normal response of a normal brain to prolonged expression of an intense emotional state” said Breggin in his book Toxic Psychiatry”(qtd. in Daydreamer, 1). Schizophrenia is a mental disorder caused by high dopamine levels that force sufferers to have a separation between their emotions and thought processes (FSSA 2003). Like Breggin, there are still people and psychologists alike that negate the existence of the disease despite scientific findings supporting its reality and the many new progresses in its treatment. The variety of treatments available is steadily growing as psychologists begin to fully understand the disease and experiment with ways to harness it. In order to grasp the treatment options of schizophrenia, one must gain a general understanding of the disorder. Schizophrenia is a very severe reoccurring and disabling medical condition. It is believed that two million Americans suffer from the illness at any given time assuming that it affects one percent of the population. Schizophrenia does not appear early in life. It usually surfaces in men in their late teens and early twenties. In women symptoms generally do not appear until their late twenties and early thirties (Spearing 1). Although not all causes of schizophrenia are known, inheritance does play a large factor in the transference of the disease. The child of a sufferer has a 10 percent chance of contracting the disorder, while an identical twin has an astonishing 50 percent chance of acquiring it. Recently, specific genes have been found that can be traced to passing on schizophrenia (Spearing 8).
Approximate Word count = 1041
Approximate Pages = 4.2
(250 words per page double spaced)
|
|
|
|
|
|